pipeline cytokinetics

  • Cytokinetics Provides Updates on Its Cardiovascular ...

    Jul 15, 2020· Cytokinetics Provides Updates on Its Cardiovascular Pipeline and Strategies to Build a Commercial Franchise at Today's Virtual Investor & Analyst .

    Get price
  • Cytokinetics | Muscle Biology Therapies | Company

    Cytokinetics scientists have discovered a robust pipeline of small molecule muscle activators and inhibitors; omecamtiv mecarbil, a cardiac myosin activator; reldesemtiv, a fast skeletal muscle troponin activator (FSTA); CK-274 and CK-271, cardiac myosin inhibitors; AMG 594, a cardiac troponin activator; and CK-601, a next-generation FSTA. Our ...

    Get price
  • Cytokinetics to update on CV pipeline at investor event ...

    Jul 15, 2020· Cytokinetics (NASDAQ:CYTK) will host a Virtual Analyst & Investor Event today starting at 8:30 am ET during which it will update on its cardiovascular (CV) pipeline and strategies to build a ...

    Get price
  • Earnings Whisper Number for CYTK: Cytokinetics

    However, the most important distinguishing feature of Cytokinetics is instead found in our commitment to innovation that has translated our focus on the cytoskeleton into a Research and Development pipeline of multiple, first-in-class compounds.

    Get price
  • Cytokinetics, Incorporated (CYTK) Stock Price, Quote ...

    Cytokinetics assumes no obligation to update its forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.Contact: Diane ...

    Get price
  • Cytokinetics Announces Licensing Collaboration and Royalty ...

    Jul 14, 2020· Cytokinetics has granted to Ji Xing an exclusive license to develop and commercialize CK-274 in China and Taiwan, in accordance with Cytokinetics' planned global registration programs.

    Get price
  • Cytokinetics and Cure SMA Renew Partnership to Advance ...

    Pipeline. We're advancing muscle biology-driven treatments for diseases characterized by compromised muscle function, muscle weakness, and fatigue. ... Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and .

    Get price
  • PRESENTATIONS | Cytokinetics, Inc.

    Pipeline. We're advancing muscle biology-driven treatments for diseases characterized by compromised muscle function, muscle weakness, and fatigue. ... Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and .

    Get price
  • 3 Biotech Stocks With Plenty of Upside in the Pipeline ...

    May 05, 2020· Cytokinetics, Inc. ... Pointing to its most advanced pipeline candidate, BDTX-189, which is currently in a Phase 1/2 trial, MasterKey-01, designed to evaluate the molecule in patients with non-small cell lung cancer (NSCLC), breast cancer and other solid tumors, the analyst likes what he's seeing. ...

    Get price
  • Cytokinetics Unveils Expanded Development Pipeline and ...

    SOUTH SAN FRANCISCO, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) plans to present an expansion of its development pipeline with the progression of two additional cardiac muscle directed drug candidates towards first-in .

    Get price
  • Cytokinetics Unveils Expanded Development Pipeline and ...

    Oct 16, 2018· "Cytokinetics pioneered the discovery of novel drug candidates that modulate sarcomere function which has translated into our broad pipeline of investigational medicines," said Fady I. Malik ...

    Get price
  • | Cytokinetics/ Astellas reldesemtiv

    Cytokinetics/ Astellas reldesemtiv. Scholar Rock - SRK 015. The SMA Drug Pipeline. Lower motor neurons of the spinal cord are the main cell type affected by SMA. When the lower motor neurons deteriorate, they no longer efficiently contact their target muscles, ultimately leading to loss of voluntary muscle contraction, which causes muscle ...

    Get price
  • Research & Pipeline - catalystpharma

    Research & Pipeline. A disease may be rare, but its treatment should not be. Catalyst is investing in the science of possibility—discovering, developing, and delivering innovative, life-changing medicines and solutions to transform patients' lives and address their most important unmet medical needs.

    Get price
  • PRESENTATIONS | Cytokinetics, Inc.

    Pipeline. We're advancing muscle biology-driven treatments for diseases characterized by compromised muscle function, muscle weakness, and fatigue. ... Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and .

    Get price
  • INVESTOR OVERVIEW | Cytokinetics, Inc.

    Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and best-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is .

    Get price
  • Information about Dicerna's Pipeline | Dicerna Pharmaceuticals

    At Dicerna, we are developing a pipeline of RNAi therapies designed to improve patients' lives by addressing the underlying cause of disease. We are developing: nedosiran (DCR-PHXC) for the treatment of primary hyperoxaluria (PH); DCR-HBVS (RG6346) for the treatment of chronic hepatitis B virus (HBV) infection in adults; and DCR-A1AT for the treatment of alpha-1 antitrypsin (A1AT) deficiency ...

    Get price
  • Cytokinetics Reviews | Glassdoor

    Dec 28, 2019· 23 Cytokinetics reviews. A free inside look at company reviews and salaries posted anonymously by employees. Best Cities for Jobs 2020 NEW! Jobs. Jobs; ... can be "lean and mean," however we continuously evaluate where our work force should be expanded as we advance our pipeline and evolve to a commercial stage biotech.

    Get price
  • Mature Pipeline Makes Cytokinetics The Biggest Bargain In ...

    May 07, 2015· Pipeline includes two of the most promising late stage drugs being developed in biotech: ALS drug Tirasemtiv and heart failure drug Omecamtiv Mecarbil. ... Mature Pipeline Makes Cytokinetics .

    Get price
  • Cytokinetics and Cure SMA Renew Partnership to Advance ...

    Pipeline. We're advancing muscle biology-driven treatments for diseases characterized by compromised muscle function, muscle weakness, and fatigue. ... Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and .

    Get price
  • Cytokinetics Keeping Its Sights On Independence

    Sep 08, 2017· In starting Cytokinetics, the idea was also to focus on one area of biology, as COR had, but without overconcentration on a single product. "From the very beginning, we've engineered into the fabric of the company a strategy of building a diverse pipeline of drug candidates, all .

    Get price
  • Pipeline | GW Pharmaceuticals, plc

    Pipeline GW's extensive research into the pharmacology of cannabinoids continues to yield highly promising data and new intellectual property across a range of therapeutic areas. GW continues to invest in research to accelerate further growth and value creation through the development of medicines that address serious unmet medical needs.

    Get price
  • Hypertrophic Cardiomyopathy Pipeline 2020 Featuring ...

    Jul 27, 2020· The "Hypertrophic Cardiomyopathy Pipeline Research Monitor, 2020 - Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook" report has been added to ResearchAndMarkets's ...

    Get price
  • Pipeline | ANAVEX

    Our pipeline includes one drug candidate and several compounds in different stages of pre-clinical study. Our proprietary SIGMACEPTOR™ Discovery Platform produced small molecule drug candidates with unique modes of action, based on our understanding of sigma receptors. Sigma receptors may be targets for therapeutics to combat many human diseases, including Alzheimer's disease.

    Get price
  • Pipeline | Ovid Therapeutics

    The Ovid pipeline includes several candidates that would potentially be the first to make a meaningful impact in the lives of individuals with rare neurological conditions like Angelman syndrome, Fragile X syndrome and DEEs.

    Get price
  • Biotech Stock Roundup: RARE drug Gets FDA Nod, Acorda ...

    Pipeline and regulatory updates were the focus this week with Ultragenyx Pharmaceutical RARE gaining FDA approval for its first drug while companies. ... Cytokinetics Down on Phase III Setback: ...

    Get price
  • Cytokinetics, Incorporated, Muscle Activation Therapy, CEO ...

    Jan 27, 2020· Treatments for Muscle Diseases, Robert I Blum, (CYTK NasdaqGS), Cytokinetics, Incorporated is pioneering the new pharmacology in developing Drug Candidates that Activate or Inhibit select Proteins involved in Muscle Force and Power causing Diseases of Severe Muscle Dysfunction and Weakness, CEO Interviews 2020, Medical Companies, Drug Development Company, Drug Discovery .

    Get price
  • Cytokinetics Provides Updates on Its Cardiovascular ...

    SOUTH SAN FRANCISCO, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) management plans to provide updates on the company's advancing cardiovascular pipeline ...

    Get price
  • PRESS RELEASES | Cytokinetics, Inc.

    Pipeline. We're advancing muscle biology-driven treatments for diseases characterized by compromised muscle function, muscle weakness, and fatigue. ... Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and .

    Get price
  • STOCK QUOTE | Cytokinetics, Inc.

    Pipeline. We're advancing muscle biology-driven treatments for diseases characterized by compromised muscle function, muscle weakness, and fatigue. ... Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and .

    Get price
  • Eyeing a potential market launch, Astellas orders up a ...

    Jul 27, 2016· A few more strategic deals would add considerable excitement to the late-stage pipeline — Job 1 at a pharma giant that long ago drifted to the unimpressive side of Big Pharma and desperately ...

    Get price